GemPharmatech Co., Ltd. logo

GemPharmatech Co., Ltd. (688046)

Market Closed
11 Aug, 06:17
SSE SSE
¥
38. 42
+1.03
+2.7547%
¥
6.85B Market Cap
- P/E Ratio
0.12% Div Yield
27.4M Volume
- Eps
¥ 37.39
Previous Close
Add Transaction
Day Range
35.9 40.75
Year Range
12.89 40.75
Want to track 688046 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688046 closed today higher at ¥38.42, an increase of 2.7547% from yesterday's close, completing a monthly increase of 60.0833% or ¥14.42. Over the past 12 months, 688046 stock gained 150.9471%.
688046 is not paying dividends to its shareholders.
The last earnings report, released on Apr 26, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688046 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

GemPharmatech Co., Ltd. (688046) FAQ

What is the stock price today?

The current price is ¥38.42.

On which exchange is it traded?

GemPharmatech Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688046.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.12%.

What is its market cap?

As of today, the market cap is 6.85B.

Has GemPharmatech Co., Ltd. ever had a stock split?

No, there has never been a stock split.

GemPharmatech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Dr. Jing Zhao Ph.D. CEO
SSE Exchange
CNE100005964 ISIN
CN Country
1,506 Employees
9 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

GemPharmatech Co., Ltd. is a reputable contract research organization that specializes in providing a broad range of genetically engineered mouse models alongside comprehensive preclinical research services to the global scientific community. Established in 2017 and with its headquarters located in Nanjing, China, the company has quickly become a pivotal player in facilitating the progress of scientific research and drug development through its innovative solutions and expert services. GemPharmatech's clientele spans across various sectors within the scientific community, underscoring its commitment to advancing research and development in the life sciences.

Products and Services

  • Mouse Models:

    The company offers an extensive array of mouse models to cater to different research needs. This includes knockout and conditional knockout models for studying gene function, disease mouse models for researching various pathologies, immunodeficient mice for immunology and cancer research, germ-free mice for gut microbiome studies, and tool mice models for a broad range of experimental applications. Additionally, GemPharmatech operates a wild mouse project, contributing to the diversity and applicability of its mouse model offerings.

  • Custom Model Generation:

    For researchers requiring specific genetic modifications in mice, GemPharmatech provides custom model generation services. This tailored service enables precise alterations in mouse genomes to create unique models that suit specific experimental requirements, thereby facilitating targeted research and discovery processes.

  • Preclinical Testing:

    To support drug development processes, the company delivers comprehensive preclinical testing services. These tests evaluate the safety and efficacy of new compounds or treatments in animal models, providing essential data before clinical trials in humans can commence.

  • Germ-Free and Microbiome:

    Apart from supplying germ-free mice, GemPharmatech offers services exploring the microbiome's impact on health and disease. This includes not only the provision of germ-free models but also customized research services involving the microbiome, catering to this rapidly expanding field of study.

  • Cell Lines and Customization:

    Understanding the need for varied biological systems in research, the company also provides cell lines along with customization services. This enables the cultivation and manipulation of specific cell types for in vitro studies, complementing the in vivo research conducted with mouse models.

  • Custom Breeding:

    To ensure researchers have access to the necessary genetic backgrounds and quantities of mice for their studies, GemPharmatech offers custom breeding services. This service allows for the production of specific mouse lines under controlled conditions, catering to extensive and complex experimental setups.

  • Animal Quality Testing:

    Maintaining high standards of research integrity and accuracy, the company provides animal quality testing services. This includes health monitoring, genetic testing, and pathogen testing to ensure the animals used in research are of the highest quality and suitable for the intended studies.

  • Other Services:

    In addition to the aforementioned services, GemPharmatech offers a range of other ancillary services to facilitate and enhance research outcomes. These services are designed to meet the varied needs of the scientific community, ensuring comprehensive support for their research endeavors.

Contact Information

Address: No. 12 Xuefu Road, Nanjing, China, 210032
Phone: 86 25 5826 5927